Literature DB >> 17322583

Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations.

Weiqiong Gu1, Xiaoying Li, Changqin Liu, Jun Yang, Lei Ye, Jingfen Tang, Yuanjun Gu, Yisheng Yang, Jie Hong, Yifei Zhang, Mingdao Chen, Guang Ning.   

Abstract

Adiponectin plays an important role in improving insulin resistance and preventing atherosclerosis. However it has been rarely reported that adiponectin influences insulin secretion because its receptor was identified in human islet beta cells. In order to investigate the direct effect of adiponectin on pancreatic islet beta cells, we performed an insulin secretion test in purified rat islets, which were incubated with adiponectin (100 ng/mL) at low (3.3 mM) and high (16.7 mM) glucose concentrations. Furthermore, cell lysates were extracted from the adiponectin-treated islets for p-AMPKalpha assay. RTPCR and immunohistochemical examination showed both adiponectin receptor 1 (AdipoR1) and receptor 2 (AdipoR2) were expressed in islet cells and AdipoR1 was predominantly expressed. Insulin secretion was significantly increased in the presence of adiponectin for 6 h at high glucose concentration. Meanwhile, the levels of phosphorylated AMPK increased with adiponectin treatment at high glucose concentrations. It is concluded that adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentration through AMPK activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17322583     DOI: 10.1385/ENDO:30:2:217

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  32 in total

1.  alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells.

Authors:  E D Targonsky; F Dai; V Koshkin; G T Karaman; A V Gyulkhandanyan; Y Zhang; C B Chan; M B Wheeler
Journal:  Diabetologia       Date:  2006-05-13       Impact factor: 10.122

2.  The regulation of AMP-activated protein kinase by phosphorylation.

Authors:  S C Stein; A Woods; N A Jones; M D Davison; D Carling
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

4.  Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

Authors:  Piero Marchetti; Silvia Del Guerra; Lorella Marselli; Roberto Lupi; Matilde Masini; Maria Pollera; Marco Bugliani; Ugo Boggi; Fabio Vistoli; Franco Mosca; Stefano Del Prato
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

5.  Dual action of adiponectin on insulin secretion in insulin-resistant mice.

Authors:  Maria Sörhede Winzell; Rubén Nogueiras; Carlos Dieguez; Bo Ahrén
Journal:  Biochem Biophys Res Commun       Date:  2004-08-13       Impact factor: 3.575

6.  Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta-cell lipotoxicity model overexpressing sterol regulatory element-binding protein-1c.

Authors:  Tokuyuki Yamashita; Kazuhiro Eto; Yukiko Okazaki; Shigeo Yamashita; Toshimasa Yamauchi; Nobuo Sekine; Ryozo Nagai; Mitsuhiko Noda; Takashi Kadowaki
Journal:  Endocrinology       Date:  2004-04-01       Impact factor: 4.736

Review 7.  Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

Authors:  D Grahame Hardie
Journal:  Endocrinology       Date:  2003-09-04       Impact factor: 4.736

Review 8.  Minireview: adiposity, inflammation, and atherogenesis.

Authors:  Christopher J Lyon; Ronald E Law; Willa A Hsueh
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

9.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  17 in total

Review 1.  The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis.

Authors:  James Cantley
Journal:  Mamm Genome       Date:  2014-08-22       Impact factor: 2.957

Review 2.  The role of adiponectin in endothelial dysfunction and hypertension.

Authors:  Edward Rojas; Daloha Rodríguez-Molina; Peter Bolli; Zafar H Israili; Judith Faría; Enzamaría Fidilio; Valmore Bermúdez; Manuel Velasco
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 3.  Adiponectin receptor signalling in the brain.

Authors:  John Thundyil; Dale Pavlovski; Christopher G Sobey; Thiruma V Arumugam
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 4.  From diabetes to renal aging: the therapeutic potential of adiponectin.

Authors:  Mehdi Karamian; Maryam Moossavi; Mina Hemmati
Journal:  J Physiol Biochem       Date:  2021-02-08       Impact factor: 4.158

5.  Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion.

Authors:  Nadeeja Wijesekara; Mansa Krishnamurthy; Alpana Bhattacharjee; Aamir Suhail; Gary Sweeney; Michael B Wheeler
Journal:  J Biol Chem       Date:  2010-08-13       Impact factor: 5.157

Review 6.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

7.  Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism.

Authors:  Kristofer S Gravenstein; Joshua K Napora; Ryan G Short; Ramona Ramachandran; Olga D Carlson; E Jeffrey Metter; Luigi Ferrucci; Josephine M Egan; Chee W Chia
Journal:  J Clin Endocrinol Metab       Date:  2011-03-09       Impact factor: 5.958

8.  Effects of Tai Chi on adiponectin and glucose homeostasis in individuals with cardiovascular risk factors.

Authors:  Rei-Yeuh Chang; Malcolm Koo; Meng-Ying Ho; Zi-Zi Lin; Zer-Ran Yu; Yen-Fen Lin; Be-Jen Wang
Journal:  Eur J Appl Physiol       Date:  2010-09-01       Impact factor: 3.078

9.  Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery.

Authors:  Fang Chai; Yong Wang; Yong Zhou; Yuan Liu; Donghua Geng; Jingang Liu
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

10.  Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.

Authors:  Michael A Trakhtenbroit; Joshua G Leichman; Mohamed F Algahim; Charles C Miller; Frank G Moody; Thomas R Lux; Heinrich Taegtmeyer
Journal:  Am J Med       Date:  2009-05       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.